Log In
Print
BCIQ
Print
Print this Print this
 

BNC375

  Manage Alerts
Collapse Summary General Information
Company Bionomics Ltd.
DescriptionPositive allosteric modulator (PAM) of nicotinic acetylcholine receptor alpha 7 (CHRNA7)
Molecular Target Nicotinic acetylcholine receptor alpha 7 (CHRNA7)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today